Distinguished leaders from fields including healthcare, law, entertainment, hospitality, and more make up our Board of Directors. While diverse in their areas of expertise, all of our members are united in their passion to advance ovarian and related gynecologic cancer research, help guide our path forward, and contribute toward our goal of finding a cure.
AI-Powered Platform Launch Sparks Nationwide Conversation The response to OCRA’s launch of the Community Accelerated Research Exchange was immediate and far-reaching. News outlets across the country picked up the story, generating more than 280 media mentions and reaching over 171 million people—a sign of just how much this groundbreaking platform, designed to connect patients, researchers, … Continued
OCRA is proud to announce the launch of the Rare Ovarian Cancer Collaborative Analytics (ROCCA) Platform, an international federated data network funded by OCRA to connect researchers globally and accelerate breakthroughs in rare ovarian cancer research. A collaborative approach to research for rare ovarian cancer ROCCA is launching with two foundational projects: one in mucinous … Continued
We Believe There’s a Better Way to Do Research So we created it. OCRA has launched the most ambitious initiative in our history. We believe it represents a fundamentally new way for research to work—one with the potential to accelerate discovery in gynecologic cancers while serving as a model for breakthroughs across all diseases. We … Continued
Get email updates about research news, action alerts, and ways to join the fight.
A global, Al-powered ecosystem designed to transform gynecologic cancer research—connecting patients, researchers, and clinicians to accelerate breakthroughs.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
